losartan has been researched along with Hyperphosphatemia in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hyperphosphatemia: A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanov, M | 1 |
| Mihailovic-Stanojevic, N | 1 |
| Grujic Milanovic, J | 1 |
| Jovovic, D | 1 |
| Miloradovic, Z | 1 |
1 other study available for losartan and Hyperphosphatemia
| Article | Year |
|---|---|
Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Creatinine; Hemodynamics; Hyp | 2011 |